« Return to News | R&D Trends

FutureCeuticals opens bioclinical research facility

Monday, March 12, 2012 02:01 PM

FutureCeuticals, an R&D and manufacturing company of fruit, vegetable and grain-based products for the functional food and dietary supplement markets, has opened Applied BioClinical (ABC), a new bioclinical research facility in Irvine, Calif.

Using advanced clinical research tools and equipment, ABC is able to measure the acute and single-dose effect of products on a wide-range of biologically relevant targets, including a host of biomarkers associated with inflammation, aging, cardiovascular conditions and metabolic conditions and serum diagnostics, among others. The ABC testing paradigm allows for the time-efficient, affordable and publishable discoveries of new functions and mechanisms of action for tested products.

"The establishment of Applied BioClinical and our state-of-the-art facilities and clinical discovery research capabilities again demonstrates ongoing investment in and commitment to delivering unique, potent, market-leading ethical products and services," said Dr. Zbigniew Pietrzkowski, chief science officer, and former vice president of R&D at FutureCeuticals. 

While Pietrzkowski and his team will continue to serve as the bioclinical R&D arm of FutureCeuticals, ABC provides a vehicle to make its bioclinical research expertise available to a wider audience within the scientific and business community and offer new opportunities for partnerships focused on co-discovery and product co-development.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.